In developing new and more successful therapies for preventing and treating cancer, it is critical to understand what normally regulates cell proliferation and cell death and what are the specific dysfunctions associated with these regulations in individual cancers. Here we review the programmed series of molecular, cellular, and biochemical events required for a cell's entrance and progression throughthe proliferativevs death processes as a starting point for such approaches to new therapies. In this article, as a starting point for such approaches, we will summarize in an overview the programmed series of molecular, cellular, and biochemical events required for entrance and progression through the proliferative vs death process.
quantitative relationship between the rate of cell proliferation and the rate of cell death. In normal adult tissues, these rates are balanced such that a steadystate (i.e., self-renewing) relationship is maintained in which the number of cells in the tissue ordinarily neither increases nor decreases continuously with time.
This steady-statebalance is regulated by a seriesof systemic hormones and local growth factors, which regulate the rates of cell proliferation and of cell death (3) . A fundamental characteristic of cancer is that, unlike their normal counterparts, the rate of proliferation of cancer cells exceeds their rate of death, resulting in continuous net growth of the cancers. Thus, malignant conversion results in a dysfunction in the regulation of cell proliferation and (or) cell death (4).
To develop new and more successful therapies for either the prevention of cancer development or the treatment of established cancer, it will be critical to understand what normally regulates cell proliferation and cell death and what are the specific dysfunctions associated with these regulations in individual cancers. In this article, as a starting point for such approaches, we will summarize in an overview the programmed series of molecular, cellular, and biochemical events required for entrance and progression through the proliferative vs death process.
Regulation and Mechanism(s) for Cell Proliferation
On the basis of autoradiographic histological techniques, Howard and Pelc (6) proposed in the 1950s that cell proliferation could be divided into a series of temporally sequential phases. Using as a point of reference the phase during which the genomic DNA is replicated, termed the synthetic or S-phase, these authors demonstrated that there was a temporal gap, termed the G1-phase, between the end of the previous mitosis and the beginning of the S-phase. Likewise, after completion of the S-phase, there was a second gap, the G2-phase, before mitosis. Based on this subdivision, a proliferative cell cycle was proposed in which cells cycle from G1-phase into S-phase into G2-phase into mitosis and then back into G1-phase, etc., again (Figure 1) . Although some cells do continuously progress through this proliferative cell cycle (e.g., crypt cells of the intestine, certain bone marrow cells, and certain skin cells), many cells are not continuously cycling; after completing mitosis, these cells enter a prolonged phase out of cycle. From this nonproliferating phase, these cells must be recruited into the proliferative cell cycle to undergo mitosis. The term G0 has been applied to the resting, nonproliferating state that characterizes these cells be- 
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Regulation and Mechanism(s) for Cell Death
Cell death can involve processes equal in complexity and regulation to those involved in cell proliferation.
This has been appreciated for many years by developmental biologists. It is this group of scientists who coined the term "programmed cell death" to distinguish between necrotic cell death and the active, orderly, and cell-type-specific death observed in developing organisms (40) . Necrotic death is a response to pathological changes initiated outside of the cell and can be elicited by any of a large series of rather nonspecific factors that change plasma membrane permeability (4). This increased plasma membrane permeability results in a cellular edema and the eventual osmotic lysis of the cell. In necrotic cell death, the cell has a passive role in initiating the process of cell death. In the other type of cell death, programmed cell death (4), a cell is activated by various signals to undergo an energy-dependent process of self-induced death. In this self-induced death, the cell is an active participant in its own demise (i.e., the cell is induced to commit "suicide" by specific signals in an otherwise normal microenvironment) (4, 41 In programmed cell death, fragmentation of the genomic DNA is an irreversible event that commits the cell to die and occurs before changes in plasma and internal membrane permeability (4). In many systems, this DNA fragmentation has been shown to result from activation of an endonuclease present within the cell's nucleus, which selectively hydrolyzes DNA at sites located between nucleosomal units, thus resulting in the typical nucleosomal-sized ladder of DNA fragments (42) (43) (44) (45) (46) (47) . In many cell types, this nuclease is calcium dependent and its activation is triggered by a sustained increase in the intracellular free Ca2 concentration initiated early in programmed cell death (48) (49) (50) (51) (52) (53) . DNA is also degraded during necrotic cell death: however, this is a late event in necrotic cells, whose plasma and internal membranes have already lysed. In necrotic death, the DNA is degraded into a continuous spectrum of sizes, a result of the simultaneous action of both lysosomal proteases and nucleases released in cells already dead (43) .
Thus, the period of DNA fragmentation (termed the F-phase) can be used to divide the temporal series of events involved in programmed cell death, much as the period of DNA synthesis (i.e., the S-phase) is used to divide the proliferative cell cycle. Once either a critical amount of cellular damage has occurred or a physiological signal has been received (e.g., changes in serum hormonal concentrations during the menstrual cycle for the endometrial cells), a major genetic reprogramming occurs within the affected cell, resulting in the activation phase (termed D1) of the death cycle (Figure 2) . During this D1-phase, certain genes that were actively transcribed and translated (e.g., genes for secretory proteins,forpolyamine synthesisenzymes, and for en- Once the intracellular Ca2 reaches a critical level, endonuclease in the cell nucleus is activated (63) . The decrease in nuclear polyamine concentrations, coupled with an increase in the nuclear concentration of certain proteins [e.g., the highly acidic (p1 3.5) a-prothymosine], induces a change in the genomic DNA conformation, opening up the linker region between nucleosomes (57). This enhances the accessibility of the DNA to the Ca2-Mg2-dependent endonuclease. Once this occurs, DNA fragmentation begins [i.e., the F portion of the death cycle ( Figure  2 )], and cell death is no longer reversible. DNA fragmentation continues until all of the genomic DNA is degraded into nucleosomalsize pieces (43) . During this F-stage, the nuclear morphology changes (i.e., chromatin condensation with nuclear margination), even though the plasma and lysosomal membranes are still intact and the mitochondria are still functional (64) . During the subsequent D2-portion of the death cycle, the Ca2-dependent tissue transglutaxninase actively cross-links various membrane proteins (60) , and cell-surface blebbing, nuclear disintegration, and eventually cellular fragmentation into clusters of membrane-bound apoptotic bodies occur. Once formed, these apoptotic bodies are rapidly phagocytized by macrophages or neighboring epithelial cells (64) .
Redefiningthe "Cell Cycle"
With the realization of the importance of programmed cell death, the older idea that cell number is determined by the proliferative cell cycle alone has been modified. Based on this modification, a redefined cell cycle ( Figure  3) has been proposed (4) . The overall cell cycle controlling cell numbers is thus composed of a multicompartment system in which the cell has at least three possible options (Figure 3) . The cell can be metabolically active but not undergoing either proliferation or death (i.e., G0 cell); undergoing cell proliferation (i.e., G0 -G1 -+ S -. Therefore, the specific signals (e.g., growth factors) that promote the entrance and progression through the cell cycle vary between different cell types.
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Regardless of these cell-type differences, cancers arising in any type of cell undergo changes in the regulation of this cell cycle. In cancer, these changes allow the rate of cell proliferation to exceed the rate of cell death, thus inducing a continuous increase in the number of cancer cells. The fact that clinical cancers are continuously increasing their cell number (i.e., growing), however, does not mean that changes in the regulation of cell proliferation are always necessary or sufficient for malignant transformation. Although malignant changes often enhance the rate of cancer cell proliferation, an imbalance in the "cell cycle" can also be induced if the normal rate of cell death is decreased in cancer cells. 74) and -independent manner (75) (76) (77) ) is an area of active research.
